Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin does not improve survival of cholangiocarcinoma patients with diabetes.

× No keyword cloud information.

8 in total

Review 1. Repurposing metformin for the treatment of gastrointestinal cancer.

Authors: Ademar Dantas Cunha Júnior; Arinilda Campos Bragagnoli; Felipe Osório Costa; José Barreto Campello Carvalheira
Journal: World J Gastroenterol Date: 2021-05-07 Impact factor: 5.742

2. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.

Authors: Charupong Saengboonmee; Wunchana Seubwai; Chawalit Pairojkul; Sopit Wongkham
Journal: Sci Rep Date: 2016-01-08 Impact factor: 4.379

3. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.

Authors: Sunbin Ling; Haiyang Xie; Fan Yang; Qiaonan Shan; Haojiang Dai; Jianyong Zhuo; Xuyong Wei; Penghong Song; Lin Zhou; Xiao Xu; Shusen Zheng
Journal: J Hematol Oncol Date: 2017-02-28 Impact factor: 17.388

Review 4. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.

Authors: Shu-Juan Ma; Yi-Xiang Zheng; Peng-Cheng Zhou; Yan-Ni Xiao; Hong-Zhuan Tan
Journal: Oncotarget Date: 2016-10-04

Review 5. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.

Authors: Mirella Pastore; Giulia Lori; Alessandra Gentilini; Maria Letizia Taddei; Giovanni Di Maira; Claudia Campani; Stefania Recalcati; Pietro Invernizzi; Fabio Marra; Chiara Raggi
Journal: Cells Date: 2020-03-03 Impact factor: 6.600

6. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells.

Authors: Sabina Di Matteo; Lorenzo Nevi; Diletta Overi; Nadine Landolina; Jessica Faccioli; Federico Giulitti; Chiara Napoletano; Andrea Oddi; Augusto M Marziani; Daniele Costantini; Agostino M De Rose; Fabio Melandro; Maria C Bragazzi; Gian Luca Grazi; Pasquale B Berloco; Felice Giuliante; Giuseppe Donato; Lorenzo Moretta; Guido Carpino; Vincenzo Cardinale; Eugenio Gaudio; Domenico Alvaro
Journal: Sci Rep Date: 2021-01-28 Impact factor: 4.379

7. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China.

Authors: Jinqing Wu; Yabo Zhou; Guizhou Wang
Journal: Gastroenterol Res Pract Date: 2021-10-29 Impact factor: 2.260

8. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.

Authors: Chin-Hsiao Tseng
Journal: Front Oncol Date: 2020-10-27 Impact factor: 6.244

8 in total